Boberg KM (2002) Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 6(3):635–647

PubMed  Article  Google Scholar 

 Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AWG (2008) International autoimmune hepatitis, simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48(1):169–76

Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354(1):54–66

CAS  PubMed  Article  Google Scholar 

Pape S, Schramm C, Gevers TJ (2019) Clinical management of autoimmune hepatitis. United European Gastroenterol J 7(9):1156–1163

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gronbaek L, Vilstrup H, Pedersen L, Christensen K, Jepsen P (2018) Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study. J Hepatol 69(4):873–877

PubMed  Article  Google Scholar 

Tanaka A, Leung PSC, Gershwin ME (2019) The genetics of primary biliary cholangitis. Curr Opin Gastroenterol 35(2):93–98

CAS  PubMed  Article  Google Scholar 

European Association for the Study of the Liver (2017) Electronic address, L. European Association for the Study of the, EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J  Hepatol 67(1):145–172

Lleo A, Leung PSC, Hirschfield GM, Gershwin EM (2020) The pathogenesis of primary biliary cholangitis: a comprehensive review. Semin Liver Dis 40(1):34–48

CAS  PubMed  Article  Google Scholar 

Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF (1999) Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 30(3):402–407

CAS  PubMed  Article  Google Scholar 

Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127(2):485–492

PubMed  Article  Google Scholar 

Karlsen TH, Folseraas T, Thorburn D, Vesterhus M (2017) Primary sclerosing cholangitis - a comprehensive review. J Hepatol 67(6):1298–1323

PubMed  Article  Google Scholar 

Folseraas T, Melum E, Franke A, Karlsen TH (2011) Genetics in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 25(6):713–726

CAS  PubMed  Article  Google Scholar 

Bansi D, Chapman R, Fleming K (1996) Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol 24(5):581–586

CAS  PubMed  Article  Google Scholar 

Chapman RW (1995) The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon? Hepatology 21(5):1473–1474

CAS  PubMed  Google Scholar 

Delle Monache M, Salvio A, Fiocca F, Basoli A, Ricci GL (1992) Primary sclerosing cholangitis: an analysis of 37 retrospective cases. Ital J Gastroenterol 24(9):485–8

Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, Prytz H, Hultcrantz R, Loof LA, Sandberg-Gertzen H, Almer S, Askling J, Ehlin A, Ekbom A (2008) Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 6(8):939–943

PubMed  Article  Google Scholar 

Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ (2018) Autoimmune hepatitis. Nat Rev Dis Primers 4:18017

PubMed  Article  Google Scholar 

Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, Neuberger JM, Day DB, Ducker SJ, Consortium UP, Sandford RN, Alexander GJ, Jones DE (2013)  Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 144(3):560–569 e7; quiz e13–4

Bahar R, Wong KA, Liu CH, Bowlus CL (2018) Update on new drugs and those in development for the treatment of primary biliary cholangitis. Gastroenterol Hepatol (N Y) 14(3):154–163

Google Scholar 

Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Moller S, Lohse AW (2013) Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol 58(3):529–534

CAS  PubMed  Article  Google Scholar 

Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH (2019) Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. JHEP Rep 1(6):437–445

PubMed  PubMed Central  Article  Google Scholar 

Gerussi A, Luca M, Cristoferi L, Ronca V, Mancuso C, Milani C, D’Amato D, O’Donnell SE, Carbone M, Invernizzi P (2020) New therapeutic targets in autoimmune cholangiopathies. Front Med (Lausanne) 7:117

Article  Google Scholar 

Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P (2018) Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers. Autoimmun Rev 17(9):854–865

PubMed  Article  Google Scholar 

Karlsen TH, Chung BK (2015) Genetic risk and the development of autoimmune liver disease. Dig Dis 33(Suppl 2):13–24

PubMed  Article  Google Scholar 

Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S (2004) Gene map of the extended human MHC. Nat Rev Genet 5(12):889–899

CAS  PubMed  Article  Google Scholar 

Tam V, Patel N, Turcotte M, Bosse Y, Pare G, Meyre D (2019) Benefits and limitations of genome-wide association studies. Nat Rev Genet 20(8):467–484

CAS  PubMed  Article  Google Scholar 

 de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Kraal G, Mulder CJ, van Nieuwkerk CM, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse AW, Weiler-Normann C, Lerch MM, Nauck M, Volzke H, Homuth G, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C,  Franke L, Bouma G, Dutch Autoimmune Hepatitis Study G, LifeLines Cohort S, P. (2014) Study of health in, Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 147(2): 443–52;e5

Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, Gu X, Walker EJ, Jing K, Juran BD, Mason AL, Myers RP, Peltekian KM, Ghent CN, Coltescu C, Atkinson EJ, Heathcote EJ, Lazaridis KN, Amos CI, Siminovitch KA (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360(24):2544–2555

CAS  PubMed  PubMed Central  Article  Google Scholar 

Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismuller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S (2010) Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138(3):1102–1111

PubMed  Article  Google Scholar 

Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R (1997) Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25(2):317–323

CAS  PubMed  Article  Google Scholar 

Naito T, Okada Y (2022) HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases. Semin Immunopathol 44(1):15–28

CAS  PubMed  Article  Google Scholar 

Morris AP (2014) Fine mapping of type 2 diabetes susceptibility loci. Curr Diab Rep 14(11):549

PubMed  PubMed Central  Article  CAS  Google Scholar 

Li Y, Sun Y, Liu Y, Wang B, Li J, Wang H, Zhang H, Wang X, Han X, Lin Q, Zhou Y, Hu L, Song Y, Bao J, Gong L, Sun M, Yuan X, Zhang X, Lian M, Xiao X, Miao Q, Wang Q, Li KK, Du S, Ma A, Li Y , Xu J, Tang S , Shi J, Xu Y, Yang L, Zhang J, Huang Z, Zhou L, Cui Y, Seldin MF,  Gershwin ME, Yan H, Zou Z, Zuo X, Tang R, Ma X, Chinese AIHC (2022) Genome-wide meta-analysis identifies novel susceptibility loci for autoimmune hepatitis Type 1. Hepatology

Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, Cordell HJ, Ducker SJ, Day DB, Heneghan MA, Neuberger JM, Donaldson PT, Bathgate AJ, Burroughs A, Davies MH, Jones DE, Alexander GJ, Barrett JC, Sandford RN, Anderson CA, UKPBC Consortium, C. (2012) Wellcome Trust case control, dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 44(10):1137–41

Wassmuth R, Depner F, Danielsson A, Hultcrantz R, Loof L, Olson R, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindgren S (2002) HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 59(5):381–387

CAS  PubMed  Article  Google Scholar 

Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, Jones DE, James OF, Bassendine MF (2006) HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44(3):667–674

CAS  PubMed  Article  Google Scholar 

Mullarkey ME, Stevens AM, McDonnell WM, Loubiere LS, Brackensick JA, Pang JM, Porter AJ, Galloway DA, Nelson JL (2005) Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis. Tissue Antigens 65(2):199–205

CAS  PubMed  Article  Google Scholar 

Invernizzi P, Ransom M, Raychaudhuri S,  Kosoy R, Lleo A, Shigeta R, Franke A, Bossa F, Amos CI, Gregersen PK, Siminovitch KA, Cusi D, de Bakker PI, Podda M, Gershwin ME,  Seldin MF, Italian PBCGSG (2012) Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. Genes Immun 13(6):461–8

Yasunami M, Nakamura H, Tokunaga K, Kawashima M, Nishida N, Hitomi Y, Nakamura M (2017) Principal contribution of HLA-DQ alleles, DQB1*06:04 and DQB1*03:01, to disease resistance against primary biliary cholangitis in a Japanese population. Sci Rep 7(1):11093

PubMed  PubMed Central  Article  CAS  Google Scholar 

Wang C, Zheng X, Tang R, Han C, Jiang Y, Wu J, Shao Y, Gao Y, Yu J, Hu Z, Zang Z, Zhao Y, Dai N, Liu L, Wu X, Nie J, Jiang B, Lin M, Li L, Wei Y, Li Y, Gong Y, Dai Y, Wang L, Ding N, Xu P, Chen S, Jiang P, Wang L, Qiu F, Wu Q, Zhang M, Jawed R, Chen R, Zhang Y, Shi X, Zhu Z, Pei H, Huang L, Tian Y, Zhang K, Qiu H, Zhao W, Gershwin ME, Chen W, Seldin MF, Liu X, Ma X, Sun L (2020) Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis. J Autoimmun 107:102372

CAS  PubMed  Article  Google Scholar 

Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P (2021) The genetic architecture of primary biliary cholangitis. Eur J Med Genet 64(9):104292

PubMed  Article  Google Scholar 

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA,  Weersma RK, Weismuller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN,  Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Muller T, Srivastava B, Dalekos G, Nothen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S,  Rich SS, Thompson WK, Schork AJ, Naess S, Thomsen I, Mayr G, Konig IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricano-Ponce I,  van Heel D, Bjornsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouilleres O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Consortium U-P, International IBDGC, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Farkkila M, Dale AM, Chapman RW, Lazaridis KN, International PSCSG, Franke A, Anderson CA, Karlsen TH (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45(6):670–5

Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E (1982) HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17(2):187–191

CAS  PubMed  Article